Link to this page
Medical Subject Headings
| Preferred Name | Cetuximab | |
| Synonyms |
MAb C225 Erbitux IMC C225 IMC-C225 C225 |
|
| Definitions |
A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000068818 |
|
| altLabel |
MAb C225 Erbitux IMC C225 IMC-C225 C225
|
|
| AQL |
AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
|
|
| cui |
C1173436 C0995188 C0879636
|
|
| DC |
1
|
|
| definition |
A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.
|
|
| DX |
20160101
|
|
| FX |
D066246
|
|
| HN |
2016 (2000)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000648 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000502 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000187 http://purl.bioontology.org/ontology/MESH/Q000235 http://purl.bioontology.org/ontology/MESH/Q000633 |
|
| Inverse of RB |
PQX0D8J21J 0
|
|
| Inverse of RO | ||
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2016; CETUXIMAB was indexed under ANTIBODIES, MONOCLONAL 2000-2013; and under ANTIBODIES, MONOCLONAL, HUMANIZED 2013-2015
|
|
| Mapped from | ||
| MDA |
20150701
|
|
| MMR |
20180702
|
|
| MN |
D12.776.377.715.548.114.224.200.750 D12.776.124.790.651.114.224.060.750 D12.776.124.486.485.114.224.060.750
|
|
| notation |
D000068818
|
|
| PA |
D000074322
|
|
| prefLabel |
Cetuximab
|
|
| RR |
205923-56-4
|
|
| TERMUI |
T000877369 T419981 T530357 T304829 T530356 T304830
|
|
| TH |
NLM (2000) FDA SRS (2013) USAN (19XX) INN (19XX) NLM (2003)
|
|
| tui |
T116 T129 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |